PerkinElmer Overview

  • Founded
  • 1937
Founded
  • Status
  • Public
  • Employees
  • 13,000
Employees
  • Stock Symbol
  • PKI
Stock Symbol
  • Investments
  • 56
  • Share Price
  • $151.26
  • (As of Wednesday Closing)

PerkinElmer General Information

Description

PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes prenatal screening and infectious-disease testing, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening to environmental analytical tools.

Contact Information

Formerly Known As
EG&G
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Diagnostic Equipment
Stock Exchange
NYS
Primary Office
  • 940 Winter Street
  • Waltham, MA 02451
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PerkinElmer Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$151.26 $149.29 $62.91 - $162.70 $16.9B 112M 961K $3.71

PerkinElmer Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 15,964,535 12,805,711 10,490,901 8,460,745
Revenue 3,233,635 2,883,673 2,777,996 2,256,982
EBITDA 788,495 513,299 504,106 443,087
Net Income 412,027 227,558 237,927 292,633
Total Assets 6,865,565 6,538,564 5,975,522 6,091,463
Total Debt 2,028,504 2,220,414 1,891,480 2,006,109
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PerkinElmer Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PerkinElmer‘s full profile, request access.

Request a free trial

PerkinElmer Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
PerkinElmer provides instruments, consumables, and services to the pharmaceutical, biomedical, chemical, environmental,
Diagnostic Equipment
Waltham, MA
13,000 As of 2019
00000000

00000000

o laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupta
0000000000 000000000
Cincinnati, OH
000 As of 0000

00000 00

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
0000000000 00000000 (0000000000)
Männedorf, Switzerland
0000 As of 0000
000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PerkinElmer Competitors (17)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Meridian Bioscience Corporation Cincinnati, OH 000
00000 00000 Corporation Männedorf, Switzerland 0000 000000000
000-000 0000000000 Corporation Hercules, CA 0000 00000000
0000000 0000000 Corporate Backed or Acquired Brea, CA 00000 000000&0
000000 00000000000 Corporate Backed or Acquired Winooski, VT 000000&0
You’re viewing 5 of 17 competitors. Get the full list »

PerkinElmer Executive Team (55)

Name Title Board Seat Contact Info
Prahlad Singh Ph.D Chief Executive Officer & Board Member
Jamey Mock Chief Financial Officer & Senior Vice President
Brian Keith Vice President & Chief Financial Officer, Diagnostics Division
Tommy Thomas Chief Financial Officer - Global Services
Alan Fletcher Vice President & General Manager of Life Sciences
You’re viewing 5 of 55 executive team members. Get the full list »

PerkinElmer Board Members (10)

Name Representing Role Since
000000 000000 Self Chairman & Board Member 000 0000
000000 000000000 Self Board Member 000 0000
0000000 0000 PerkinElmer Board Member 000 0000
00000 0000000 00.0 Self Board Member 000 0000
0000000 00000 00.0 PerkinElmer Chief Executive Officer & Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

PerkinElmer Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PerkinElmer Investments & Acquisitions (56)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000000 07-Jan-2021 000000000000000000 00000 Diagnostic Equipment 0000000 00000 00.0
00000000 22-Dec-2020 00000 00000 00 00.000 Biotechnology 0000 00000000
000000 00000000000 16-Dec-2020 00000 00000 00 000.00 Laboratory Services (Healthcare)
0000000 000000000 02-Nov-2020 000000000000000000 00000 Other Pharmaceuticals and Biotechnology 0000000 00000 00.0
Meizheng Group 30-Oct-2019 Merger/Acquisition 00000 Other Commercial Services 00000 0000
You’re viewing 5 of 56 investments and acquisitions. Get the full list »

PerkinElmer Subsidiaries (17)

Company Name Industry Location Founded
Vanadis Diagnostics Biotechnology Sweden 2013
00000 0000000000 Other Healthcare Technology Systems Mansfield, United Kingdom 0000
00000000 00000 Other Commercial Services Beijing, China 0000
0000000 00000000 0 Industrial Chemicals Marlborough, MA 0000
0000 0000000000 Laboratory Services (Healthcare) Austin, TX 0000
You’re viewing 5 of 17 subsidiaries. Get the full list »

PerkinElmer Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000 000 27-Jul-2006 000000000000000000 Completed
  • 00000000000
00000 29-Oct-2003 00000 00000 00 00.00 Completed
  • 3 buyers
00000 06-Jun-2002 00000 00000 00 00.00 Completed
  • 3 buyers
Voltarc Technologies 02-Oct-1997 Merger/Acquisition Completed
To view PerkinElmer’s complete exits history, request access »